The Impact of Post-tetanic Count on Subsequent Train-of-four During Recovery From Rocuronium
Sponsored by Maisonneuve-Rosemont Hospital
About this trial
Last updated 16 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 16 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Patient having general anesthesia in dorsal decubitus with both arm available for at least an hour and a half
Exclusion Criteria
* Age >75 or <18
* Neuromuscular disease
* difficult laryngoscopy predicted
* Allergy to rocuronium
* Malignant hyperthermia
* Full stomach
* Drugs the influence neuromuscular blockers
* Decision of the clinician to exclude his patient
